Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
National Black HIV/AIDS Awareness Day: Combatting Stigma & Cultural Stereotypes

African-Americans are infected with HIV at eight times the rate of white Americans and accounted for 44 percent of HIV diagnoses in 2014.

Published
12 hours ago
From
NewsOne
God and condoms: perspectives on family planning and faith

The subject of contraception is a hot topic in faith communities, which made for some exciting discussions at the recent International Conference on Family Planning in Indonesia. The conference heard that contrary to popular belief, many faith-based organisations do support family planning as a process that helps improve people’s quality of life. For the first time, around 80 representatives from different faith groups attending the conference spoke of their commitment to continue informing and educating their communities on family planning. The consensus was that it is consistent with faith values, in order to protect the rights of women, children and families.

Published
05 February 2016
From
Key Correspondents
Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice

A combination of fine-particle formulations of the drugs atazanavir and ritonavir, plus an immune-dampener drug designed to induce cells to keep hold of the drugs for longer,

Published
05 February 2016
By
Gus Cairns
South Africa: Police hamper HIV prevention efforts with drug users

Daily police harassment is undermining HIV prevention efforts among people who inject drugs, according to the TB/HIV Care Association (THCA). The association has recorded almost 250 “abuse” cases among this group in just three months, according to a report released today.

Published
04 February 2016
From
Health-e
US: Study shows direct link between state spending habits and AIDS deaths

American states with higher spending on social services and public health -- such as education and income support -- per person living in poverty (according to the federal poverty threshold) had significantly lower HIV/AIDS case rates and fewer AIDS deaths.

Published
04 February 2016
From
Eurekalert Inf Dis
People Are So Desperate For The Drug That Blocks HIV They're “Cheating” The NHS

It’s called “clinic hopping” and involves lying to doctors to get the drug Truvada. Those involved spoke to BuzzFeed News about the lengths they’ll go to for PrEP – and why.

Published
04 February 2016
From
BuzzFeed News
Prison needle programs touted to reduce HIV and Hep C

Researchers hope new government's "evidence-based" outlook will open door for safe injection programs in Canadian jails.

Published
03 February 2016
From
Toronto Star
President Obama seeks $1.1 billion to fight heroin and opiate epidemic

As heroin- and opioid-related deaths have reached unprecedented levels in the United States, President Barack Obama has asked for an additional $1.1 billion to fund treatment of heroin and opiate addiction. The majority of the money would go toward working with states to expand access to medication-assisted treatment for opiate addiction, according to the proposal.

Published
03 February 2016
From
The Independent
Activists United and Ignited by Urgency for HIV Prevention in Europe: EATG and AVAC call for the rollout of PrEP as a proven HIV prevention strategy

Initiated and organised entirely by the community of people living with and at risk for HIV, the second European HIV Prevention Summit brought together representatives of civil society, the pharmaceutical industry, researchers and academia in Brussels between 29 and 31 January. In addition to a thorough examination of PrEP (pre-exposure prophylaxis), the summit discussed the latest developments in the research fields of vaccines, rectal and vaginal microbicides and antibodies and their utility in HIV prevention.

Published
03 February 2016
From
EATG
European Medicines Agency Validates Gilead’s Type II Variation Application for Truvada for Reducing the Risk of Sexually Acquired HIV

Gilead Sciences announced today that the company’s Type II variation application for once-daily Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk, a strategy known as pre-exposure prophylaxis or PrEP, has been fully validated and is now under evaluation by the European Medicines Agency (EMA).

Published
01 February 2016
From
Gilead press release
← First12345...454Next →

Filter by country